Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Actavis expands presence in Russia
The purchase of a majority stake in the Russian manufacturing facility strengthens the company’s position in the Russian generics market, the company said. Russia is one of the
The purchase of a majority stake in the Russian manufacturing facility strengthens the company’s position in the Russian generics market, the company said. Russia is one of the
The agreement represents a significant initiative to undertake a large-scale approach to gene function analysis using shRNAi 'knock down' in genetically engineered mice as models for human biology.
The cash will come from agreements with new institutional investors in Australia, existing institutional investors in the US and a founding member of the Prana. As a result,
The approval decision follows a positive opinion issued by the European Medicines Agency. Lilly and Amylin anticipate launching Byetta in Europe in 2007. Byetta, also known as exenatide,
The broadened designation includes all types of acute hereditary angioedema (HAE) attacks. HAE is a rare and life-threatening inflammatory condition for which there is no approved therapy in
Orphan drug designation qualifies Repligen for seven years of exclusive marketing rights in the US. The designation also provides for benefit from certain tax credits and waives the
Santarus expects to receive a $15 million upfront license fee payable under the over-the-counter license agreement. Under the terms of the agreement, Schering-Plough will be responsible for the
The agreement requires Nippon Shinyaku to pay both royalties and milestone payments to Pharmion upon the achievement of certain regulatory and sales milestones, and also provides Nippon Shinyaku
The NPRL2 gene is believed to be important in the genesis of multiple types of cancer, including lung cancer and renal cell cancer. The gene is licensed to
Dupuytren's contracture is a disabling and recurring condition in which the joints in the hand contract, impairing patients' ability to straighten and move their fingers. The primary endpoint